<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36147602</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients.</ArticleTitle><Pagination><StartPage>1000291</StartPage><MedlinePgn>1000291</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1000291</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2022.1000291</ELocationID><Abstract><AbstractText>Zonulin has previously been related to intestinal permeability in various inflammatory diseases, and more recently to the physiopathology of severe COVID-19 infections. We analysed serum samples from a previous study of a Peruvian cohort of hospitalised COVID-19 patients, for the quantification of zonulin by sandwich ELISA. Comparisons with clinical data, haematological and biochemical parameters and cytokine/chemokine levels were made. We found higher baseline zonulin levels in deceased patients, and zonulin was associated with fatal outcome in multivariable analyses, even after adjustment for age, gender, and obesity. There were also positive correlations between zonulin, creatinine, D-dimer values and prothrombin time, while inverse correlations were found for Sa/FiO<sub>2</sub> ratio and CCL5 (RANTES). Further longitudinal studies are recommended to analyse the variation of zonulin levels over time as well as their relationship with long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Palomino-Kobayashi, Yma&#xf1;a, Ruiz, Mayanga-Herrera, Ugarte-Gil and Pons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palomino-Kobayashi</LastName><ForeName>Luciano A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Grupo Enfermedades Infecciosas Emergentes. Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yma&#xf1;a</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Grupo Enfermedades Infecciosas Emergentes. Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grupo Enfermedades Infecciosas Emergentes. Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayanga-Herrera</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratorio de Cultivo Celular e Inmunolog&#xed;a, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugarte-Gil</LastName><ForeName>Manuel F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Grupo Peruano de Estudio de Enfermedades Autoinmunes Sist&#xe9;micas, Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018946">Chemokine CCL5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006242">Haptoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C408043">zonulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Cell Infect Microbiol. 2022 Dec 15;12:1062174. doi: 10.3389/fcimb.2022.1062174</RefSource><PMID Version="1">36590584</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018946" MajorTopicYN="N">Chemokine CCL5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006242" MajorTopicYN="Y">Haptoglobins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010539" MajorTopicYN="N">Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="Y">Protein Precursors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ELISA</Keyword><Keyword MajorTopicYN="N">Peru</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">microbial translocation</Keyword><Keyword MajorTopicYN="N">zonulin</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36147602</ArticleId><ArticleId IdType="pmc">PMC9485714</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2022.1000291</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ARDS Definition Task Force (2012). Acute respiratory distress syndrome: the Berlin definition. JAMA 307, 2526&#x2013;2533. doi:&#xa0;10.1001/jama.2012.5669</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E. B., Rangel &#xc9;.B. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 40, 905&#x2013;919. doi:&#xa0;10.1007/s10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A., Reed A. B., Ponzo S., Yassaee A., Aral M., Plans D., et al. . (2021). Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PloS One 16, e0247461. doi:&#xa0;10.1371/journal.pone.0247461</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z., Yang Y., Zhang J. (2021). Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. BMC Public Health 21, 1505. doi:&#xa0;10.1186/s12889-021-11546-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11546-6</ArticleId><ArticleId IdType="pmc">PMC8334342</ArticleId><ArticleId IdType="pubmed">34348687</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale V., Capurso G., Ianiro G., Gasbarrini A., Arcidiacono P. G., Alvaro D. (2020). Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig. Liver Dis. 52, 1383&#x2013;1389. doi:&#xa0;10.1016/j.dld.2020.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7494274</ArticleId><ArticleId IdType="pubmed">33023827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chancharoenthana W., Leelahavanichkul A., Ariyanon W., Vadcharavivad S., Phatcharophaswattanakul S., Kamolratanakul S., et al. . (2021). Leaky gut syndrome is associated with endotoxemia and serum (1&#x2192;3)-&#x3b2;-D-Glucan in severe dengue infection. Microorganisms 9, 2390. doi:&#xa0;10.3390/microorganisms9112390</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9112390</ArticleId><ArticleId IdType="pmc">PMC8625530</ArticleId><ArticleId IdType="pubmed">34835514</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie Z. G., Zewotir T. (2021). Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 21, 855. doi:&#xa0;10.1186/s12879-021-06536-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinh D. M., Volpe G. E., Duffalo C., Bhalchandra S., Tai A. K., Kane A. V., et al. . (2015). Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211, 19&#x2013;27. doi:&#xa0;10.1093/infdis/jiu409</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu409</ArticleId><ArticleId IdType="pmc">PMC4326316</ArticleId><ArticleId IdType="pubmed">25057045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91, 151&#x2013;175. doi:&#xa0;10.1152/physrev.00003.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00003.2008</ArticleId><ArticleId IdType="pubmed">21248165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. (2020). All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res 9, F1000 Faculty Rev&#x2013;69. doi:&#xa0;10.12688/f1000research.20510.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.20510.1</ArticleId><ArticleId IdType="pmc">PMC6996528</ArticleId><ArticleId IdType="pubmed">32051759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui H. (2016). Endotoxin and other microbial translocation markers in the blood: A clue to understand leaky gut syndrome. Cell Mol. Med. 02, 3. doi:&#xa0;10.21767/2573-5365.100023</Citation><ArticleIdList><ArticleId IdType="doi">10.21767/2573-5365.100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J. C. C., Muecksch F., Finkin S., Tokuyama M., et al. . (2021). Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639&#x2013;644. doi:&#xa0;10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M. A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., et al. . (2022). Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: Identification of diagnostic biomarkers. Front. Immunol. 13, 848886. doi:&#xa0;10.3389/fimmu.2022.848886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargari G., Mantegazza G., Taverniti V., Del Bo&#x2019; C., Bernardi S., Andres-Lacueva C., et al. . (2021). Bacterial DNAemia is associated with serum zonulin levels in older subjects. Sci. Rep. 11, 11054. doi:&#xa0;10.1038/s41598-021-90476-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90476-0</ArticleId><ArticleId IdType="pmc">PMC8154904</ArticleId><ArticleId IdType="pubmed">34040086</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L. B., Dweep H., Yin X., Wang H., Damra M., Goldman A. R., et al. . (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front. Immunol. 12, 779064. doi:&#xa0;10.3389/fimmu.2021.686240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalan N., Senthil S., Prabakar N. L., Senguttuvan T., Bhaskar A., Jagannathan M., et al. . (2022). Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care&#x2013;an experience from south India. PloS One 17, e0263471. doi:&#xa0;10.1371/journal.pone.0263471</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263471</ArticleId><ArticleId IdType="pmc">PMC8812932</ArticleId><ArticleId IdType="pubmed">35113971</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff A., Kavanaugh M., Ramgobin D., McClafferty B., Aggarwal C. S., Golamari R., et al. . (2021). Gastrointestinal manifestations of COVID-19: A review of what we know. Ochsner J. 21, 177&#x2013;180. doi:&#xa0;10.31486/toj.20.0086</Citation><ArticleIdList><ArticleId IdType="doi">10.31486/toj.20.0086</ArticleId><ArticleId IdType="pmc">PMC8238098</ArticleId><ArticleId IdType="pubmed">34239378</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B. M., Cheruiyot I., Vikse J., Mutua V., Kipkorir V., Benoit J., et al. . (2020). Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis. Acta BioMed. 91, e2020008. doi:&#xa0;10.23750/abm.v91i3.10217</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i3.10217</ArticleId><ArticleId IdType="pmc">PMC7716963</ArticleId><ArticleId IdType="pubmed">32921706</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I., Pranata R. (2020). Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J. Intensive Care 8, 36. doi:&#xa0;10.1186/s40560-020-00453-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00453-4</ArticleId><ArticleId IdType="pmc">PMC7245646</ArticleId><ArticleId IdType="pubmed">32483488</ArticleId></ArticleIdList></Reference><Reference><Citation>Josyabhatla R., Kamdar A. A., Armbrister S. A., Daniel R., Boukas K., Smith K. G., et al. . (2021). Recognizing a MIS-chievous cause of acute viral gastroenteritis. Front. Pediatr. 9, 748368. doi:&#xa0;10.3389/fped.2021.748368</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.748368</ArticleId><ArticleId IdType="pmc">PMC8588082</ArticleId><ArticleId IdType="pubmed">34778138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J. S., Lee J. Y., Yang J. W., Lee K. H., Effenberger M., Szpirt W., et al. . (2021). Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 11, 316&#x2013;329. doi:&#xa0;10.7150/thno.49713</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.49713</ArticleId><ArticleId IdType="pmc">PMC7681075</ArticleId><ArticleId IdType="pubmed">33391477</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; A. O., Ak&#x131;n F., Yazar A., Metin Akcan &#xd6;., Topcu C., Ayd&#x131;n O. Zonulin and claudin-5 levels in multisystem inflammatory syndrome and SARS-CoV-2 infection in children. J. Paediatr. Child Health in press. doi:&#xa0;10.1111/jpc.16033</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16033</ArticleId><ArticleId IdType="pmc">PMC9347651</ArticleId><ArticleId IdType="pubmed">35638118</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsounas I., Kaltsa G., Siakavellas S. I., Bamias G. (2015). Markers of bacterial translocation in end-stage liver disease. World J. Hepatol. 7, 2264&#x2013;2273. doi:&#xa0;10.4254/wjh.v7.i20.2264</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v7.i20.2264</ArticleId><ArticleId IdType="pmc">PMC4568487</ArticleId><ArticleId IdType="pubmed">26380651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M. M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T. I., et al. . (2020). SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50&#x2013;54. doi:&#xa0;10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Wang H., Shi S., Xiao J. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis. Postgrad. Med. J. in press. doi:&#xa0;10.1136/postgradmedj-2021-139939</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-139939</ArticleId><ArticleId IdType="pubmed">37063032</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorens S., Nava E., Mu&#xf1;oz-L&#xf3;pez M., S&#xe1;nchez-Larsen &#xc1;., Segura T. (2021). Neurological symptoms of COVID-19: The zonulin hypothesis. Front. Immunol. 12, 665300. doi:&#xa0;10.3389/fimmu.2021.665300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665300</ArticleId><ArticleId IdType="pmc">PMC8107207</ArticleId><ArticleId IdType="pubmed">33981312</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel U., Mehta D., Patel N., Kelkar R., Akrmah M., et al. . (2021). Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evidence-Based Med. 26, 107&#x2013;108. doi:&#xa0;10.1136/bmjebm-2020-111536</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2020-111536</ArticleId><ArticleId IdType="pmc">PMC7493072</ArticleId><ArticleId IdType="pubmed">32934000</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti G., Tincati C., Silvestri G. (2013). Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26, 2&#x2013;18. doi:&#xa0;10.1128/CMR.00050-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00050-12</ArticleId><ArticleId IdType="pmc">PMC3553668</ArticleId><ArticleId IdType="pubmed">23297256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashaqi S., Kallamadi R., Matta A., Quan S. F., Patel S. L., Combs D., et al. . (2022). Obstructive sleep apnea as a risk factor for COVID-19 severity-the gut microbiome as a common player mediating systemic inflammation via gut barrier dysfunction. Cells 11, 1569. doi:&#xa0;10.3390/cells11091569</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11091569</ArticleId><ArticleId IdType="pmc">PMC9101605</ArticleId><ArticleId IdType="pubmed">35563874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad S., Aziz R., Al Mahri S., Malik S. S., Haji E., Khan A. H., et al. . (2021). Obesity and COVID-19: what makes obese host so vulnerable? Immun. Ageing 18, 1. doi:&#xa0;10.1186/s12979-020-00212-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00212-x</ArticleId><ArticleId IdType="pmc">PMC7779330</ArticleId><ArticleId IdType="pubmed">33390183</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A., Cammisotto V., Cangemi R., Ferro D., Miele M. C., De Angelis M., et al. . (2021). Low-grade endotoxemia and thrombosis in COVID-19. Clin. Transl. Gastroenterol. 12, e00348. doi:&#xa0;10.14309/ctg.0000000000000348</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ctg.0000000000000348</ArticleId><ArticleId IdType="pmc">PMC8183715</ArticleId><ArticleId IdType="pubmed">34092777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M. J., Yma&#xf1;a B., Mayanga-Herrera A., S&#xe1;enz Y., Alvarez-Erviti L., Tapia-Rojas S., et al. . (2021). Cytokine profiles associated with worse prognosis in a hospitalized Peruvian COVID-19 cohort. Front. Immunol. 12, 700921. doi:&#xa0;10.3389/fimmu.2021.700921</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700921</ArticleId><ArticleId IdType="pmc">PMC8440968</ArticleId><ArticleId IdType="pubmed">34539631</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph H. E., Fiege J. K., Thielen B. K., Mickelson C. K., Shiratori M., Barroso-Batista J., et al. . (2021). Genetic ancestry effects on the response to viral infection are pervasive but cell type specific. Science 374, 1127&#x2013;1133. doi:&#xa0;10.1126/science.abg0928</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg0928</ArticleId><ArticleId IdType="pmc">PMC8957271</ArticleId><ArticleId IdType="pubmed">34822289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittirsch D., Flierl M. A., Nadeau B. A., Day D. E., Huber-Lang M. S., Grailer J. J., et al. . (2013). Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. Am. J. Physiol. Lung Cell Mol. Physiol. 304, L863&#x2013;L872. doi:&#xa0;10.1152/ajplung.00196.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00196.2012</ArticleId><ArticleId IdType="pmc">PMC3680747</ArticleId><ArticleId IdType="pubmed">23564505</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffler L., Crane A., Heyne H., T&#xf6;njes A., Schleinitz D., Ihling C. H., et al. . (2018). Widely used commercial ELISA does not detect precursor of Haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Front. Endocrinol. 9, 22. doi:&#xa0;10.3389/fendo.2018.00022</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00022</ArticleId><ArticleId IdType="pmc">PMC5807381</ArticleId><ArticleId IdType="pubmed">29459849</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X.-R., Geng R., Li Q., Chen Y., Li S.-F., Wang Q., et al. . (2022). ACE2-independent infection of T lymphocytes by SARS-CoV-2. Sig. Transduct Target Ther. 7, 83. doi:&#xa0;10.1038/s41392-022-00919-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00919-x</ArticleId><ArticleId IdType="pmc">PMC8914143</ArticleId><ArticleId IdType="pubmed">35277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Skardelly M., Armbruster F. P., Meixensberger J., Hilbig H. (2009). Expression of zonulin, c-kit, and glial fibrillary acidic protein in human gliomas. Transl. Oncol. 2, 117&#x2013;120. doi: 10.1593/tlo.09115</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/tlo.09115</ArticleId><ArticleId IdType="pmc">PMC2730142</ArticleId><ArticleId IdType="pubmed">19701495</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto A., Qui&#xf1;ones-Laveriano D. M., Aza&#xf1;ero J., Chumpitaz R., Claros J., Salazar L., et al. . (2022). Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian reference hospital. PloS One 17, e0264789. doi:&#xa0;10.1371/journal.pone.0264789</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264789</ArticleId><ArticleId IdType="pmc">PMC8890646</ArticleId><ArticleId IdType="pubmed">35235613</ArticleId></ArticleIdList></Reference><Reference><Citation>Stehle J. R., Leng X., Kitzman D. W., Nicklas B. J., Kritchevsky S. B., High K. P. (2012). Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1212&#x2013;1218. doi:&#xa0;10.1093/gerona/gls178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/gls178</ArticleId><ArticleId IdType="pmc">PMC3636679</ArticleId><ArticleId IdType="pubmed">22960476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgeon C., Fasano A. (2016). Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 4, e1251384. doi:&#xa0;10.1080/21688370.2016.1251384</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2016.1251384</ArticleId><ArticleId IdType="pmc">PMC5214347</ArticleId><ArticleId IdType="pubmed">28123927</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi A., Lammers K. M., Goldblum S., Shea-Donohue T., Netzel-Arnett S., Buzza M. S., et al. . (2009). Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc. Natl. Acad. Sci. U.S.A. 106, 16799&#x2013;16804. doi:&#xa0;10.1073/pnas.0906773106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906773106</ArticleId><ArticleId IdType="pmc">PMC2744629</ArticleId><ArticleId IdType="pubmed">19805376</ArticleId></ArticleIdList></Reference><Reference><Citation>Trottein F., Sokol H. (2020). Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 32, 107915. doi:&#xa0;10.1016/j.celrep.2020.107915</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107915</ArticleId><ArticleId IdType="pmc">PMC7332457</ArticleId><ArticleId IdType="pubmed">32649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzzan M., Corcos O., Martin J. C., Treton X., Bouhnik Y. (2020). Why is SARS-CoV-2 infection more severe in obese men? the gut lymphatics - lung axis hypothesis. Med. Hypotheses 144, 110023. doi:&#xa0;10.1016/j.mehy.2020.110023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110023</ArticleId><ArticleId IdType="pmc">PMC7308746</ArticleId><ArticleId IdType="pubmed">32593832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakil M. K., Mansoori Y., Al-Awsi G. R. L., Hosseinipour A., Ahsant S., Ahmadi S., et al. . (2022). Individual genetic variability mainly of proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease. J. Med. Virol. 94, 4088&#x2013;4096. doi:&#xa0;10.1002/jmv.27849</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27849</ArticleId><ArticleId IdType="pmc">PMC9348290</ArticleId><ArticleId IdType="pubmed">35538614</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignesh R., Swathirajan C. R., Tun Z. H., Rameshkumar M. R., Solomon S. S., Balakrishnan P. (2020). Could perturbation of gut microbiota possibly exacerbate the severity of COVID-19 via cytokine storm? Front. Immunol. 11, 607734. doi:&#xa0;10.3389/fimmu.2020.607734</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.607734</ArticleId><ArticleId IdType="pmc">PMC7868418</ArticleId><ArticleId IdType="pubmed">33569053</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Ma Z., Lei Y. (2021). A meta-analysis of the association between obesity and COVID-19. Epidemiol. Infect. 149, e11. doi:&#xa0;10.1017/S0950268820003027</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820003027</ArticleId><ArticleId IdType="pmc">PMC7844214</ArticleId><ArticleId IdType="pubmed">33349290</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L. M., Gilboa T., Ogata A. F., Senussi Y., Lazarovits R., Boribong B. P., et al. . (2021). Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. 131, e149633. doi:&#xa0;10.1172/JCI149633</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L. M., Swank Z., Gilboa T., Senussi Y., Kenyon V., Papadakis L., et al. . (2022). Zonulin antagonist, larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: A case series. Crit. Care Explor. 4, e0641. doi:&#xa0;10.1097/CCE.0000000000000641</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000641</ArticleId><ArticleId IdType="pmc">PMC8860335</ArticleId><ArticleId IdType="pubmed">35211683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Qin L., Zhang P., Li K., Liang L., Sun J., et al. . (2020). Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5, e139834. doi:&#xa0;10.1172/jci.insight.139834</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.139834</ArticleId><ArticleId IdType="pmc">PMC7406242</ArticleId><ArticleId IdType="pubmed">32501293</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>